DOBBIE JAMES LAMELLAR THERAPEUTICS LIMITED,DOBBIE James Lamellar Therapeutics Limited
申请号：
SI200432263
公开号：
SI1667693T1
申请日:
2004.08.31
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
Compositions comprising therapeutically effective amounts of lamellar bodies for the modification of linear macromolecules are disclosed. These lamellar compositions are useful in the treatment of conditions or diseases characterized by a preponderance of heavy mucous secretions, such as otitis media, cystic fibrosis, bronchitis, sinusitis and nasal congestion. Methods of treating these diseases and conditions by administering a therapeutically effective amount of a composition to a patient requiring such treatment are also disclosed.
